Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone versus morphine for postoperative limb fracture pain
IRCT20200708048062N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of oxycodone and morphine in tibia fracture and femoral fracture (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Pain intensity. Started Aug 2020; status: completed.
02
Drugs
oxycodonemorphine
03
Conditions
tibia fracturefemoral fracture
Beyond the preview
Go deeper on IRCT20200708048062N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200708048062N1.